Evidence map›Paper›PMID 39135850›Full record

ArticleJournal of multidisciplinary healthcare2024

A Machine Learning Method for Differentiation Crohn's Disease and Intestinal Tuberculosis.

Yufeng Shu, Zhe Chen, Jingshu Chi, Sha Cheng, Huan Li, Peng Liu, Ju Luo

Abstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Urinary lipoarabinomannan for gastrointestinal tuberculosis: Another tool in the kit.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yufeng Shu *Department of Gastroenterology, Third Xiangya Hospital, Central South University., Changsha, Hunan, People's Republic of China.
Zhe Chen *Department of Gerontology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China., Changsha, Hunan, People's Republic of China.
Jingshu ChiDepartment of Gastroenterology, Third Xiangya Hospital, Central South University., Changsha, Hunan, People's Republic of China.
Sha ChengDepartment of Gastroenterology, Third Xiangya Hospital, Central South University., Changsha, Hunan, People's Republic of China.
Huan LiDepartment of Gastroenterology, Third Xiangya Hospital, Central South University., Changsha, Hunan, People's Republic of China.ORCID 0000-0001-8568-3151
Peng LiuDepartment of Gastroenterology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China., Changsha, Hunan, People's Republic of China.
Ju LuoDepartment of Gerontology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China., Changsha, Hunan, People's Republic of China.ORCID 0000-0002-5595-9513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Whether machine learning (ML) can assist in the diagnosis of Crohn's disease (CD) and intestinal tuberculosis (ITB) remains to be explored. Methods: We collected clinical data from 241 patients, and 51 parameters were included. Six ML methods were tested, including logistic regression, decision tree, k-nearest neighbor, multinomial NB, multilayer perceptron, and XGBoost. SHAP and LIME were subsequently introduced as interpretability methods. The ML model was tested in a real-world clinical practice and compared with a multidisciplinary team (MDT) meeting. Results: XGBoost displays the best performance among the six ML models. The diagnostic AUROC and the accuracy of XGBoost were 0.946 and 0.884, respectively. The top three clinical features affecting our ML model's result prediction were T-spot, pulmonary tuberculosis, and onset age. The ML model's accuracy, sensitivity, and specificity in clinical practice were 0.860, 0.833, and 0.871, respectively. The agreement rate and kappa coefficient of the ML and MDT methods were 90.7% and 0.780, respectively (P<0.001). Conclusion: We developed an ML model based on XGBoost. The ML model could provide effective and efficient differential diagnoses of ITB and CD with diagnostic bases. The ML model performs well in real-world clinical practice, and the agreement between the ML model and MDT is strong.

Indexed as

artificial intelligencecrohn’s diseaseintestinal tuberculosismachine learningmultidisciplinary team

Identifiers

PMID39135850
PMCPMC11318598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.